AAAAAA

   
Results: 1-15 |
Results: 15
Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years
Authors: Gunthard, HF Havlir, DV Fiscus, S Zhang, ZQ Eron, J Mellors, J Gulick, R Frost, SDW Brown, AJL Schleif, W Valentine, F Jonas, L Meibohm, A Ignacio, CC Isaacs, R Gamagami, R Emini, E Haase, A Richman, DD Wong, JK
Citation: Hf. Gunthard et al., Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years, J INFEC DIS, 183(9), 2001, pp. 1318-1327
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy
Authors: Huang, W De Gruttola, V Fischl, M Hammer, S Richman, D Havlir, D Gulick, R Squires, K Mellors, J
Citation: W. Huang et al., Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy, J INFEC DIS, 183(10), 2001, pp. 1455-1465
Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts
Authors: Tarwater, PM Mellors, J Gore, ME Margolick, JB Phair, J Detels, R Munoz, A
Citation: Pm. Tarwater et al., Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts, AM J EPIDEM, 154(7), 2001, pp. 675-681
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan
Authors: DeGruttola, V Dix, L D'Aquila, R Holder, D Phillips, A Ait-Khaled, M Baxter, J Clevenbergh, P Hammer, S Harrigan, R Katzenstein, D Lanier, R Miller, M Para, M Yerly, S Zolopa, A Murray, J Patick, A Miller, V Castillo, S Pedneault, L Mellors, J
Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase
Authors: Lederman, MM McKinnis, R Kelleher, D Cutrell, A Mellors, J Neisler, M Cooney, E Haas, DW Haubrich, R Stanford, J Horton, J Landay, A Spreen, W
Citation: Mm. Lederman et al., Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase, AIDS, 14(17), 2000, pp. 2635-2642
Salvage therapy for HIV-1 infection - the challenge grows
Authors: Mellors, J Montaner, J
Citation: J. Mellors et J. Montaner, Salvage therapy for HIV-1 infection - the challenge grows, LANCET, 355(9213), 2000, pp. 1435-1435
Visions for a sustainable Europe
Authors: Rotmans, J van Asselt, M Anastasi, C Greeuw, S Mellors, J Peters, S Rothman, D Rijkens, N
Citation: J. Rotmans et al., Visions for a sustainable Europe, FUTURES, 32(9-10), 2000, pp. 809-831
Modeling the long-term outcomes and costs of HIV Antiretroviral therapy using HIV RNA levels: Application to a clinical trial
Authors: Cook, J Dasbach, E Coplan, P Markson, L Yin, DP Meibohm, A Nguyen, BY Chodakewitz, J Mellors, J
Citation: J. Cook et al., Modeling the long-term outcomes and costs of HIV Antiretroviral therapy using HIV RNA levels: Application to a clinical trial, AIDS RES H, 15(6), 1999, pp. 499-508
Ritonavir and saquinavir combination therapy for the treatment of HIV infection
Authors: Cameron, DW Japour, AJ Xu, Y Hsu, A Mellors, J Farthing, C Cohen, C Poretz, D Markowitz, M Follansbee, S Angel, JB McMahon, D Ho, D Devanarayan, V Rode, R Salgo, MP Kempf, DJ Granneman, R Leonard, JM Sun, E
Citation: Dw. Cameron et al., Ritonavir and saquinavir combination therapy for the treatment of HIV infection, AIDS, 13(2), 1999, pp. 213-224
HIV mediates a productive infection of the brain
Authors: Wiley, CA Achim, CL Christopherson, C Kidane, Y Kwok, S Masliah, E Mellors, J Radhakrishnan, L Wang, GJ Soontornniyomkij, V
Citation: Ca. Wiley et al., HIV mediates a productive infection of the brain, AIDS, 13(15), 1999, pp. 2055-2059
Testing time as resistant HIV-1 faces next wave of attack
Authors: Mellors, J
Citation: J. Mellors, Testing time as resistant HIV-1 faces next wave of attack, LANCET, 354(9173), 1999, pp. 135-135
Better salvage therapy for HIV-1 infection still needed
Authors: Montaner, J Mellors, J
Citation: J. Montaner et J. Mellors, Better salvage therapy for HIV-1 infection still needed, LANCET, 353(9167), 1999, pp. 1857-1857
Progress in HIV-1 therapy continues on upward track
Authors: Montaner, J Mellors, J
Citation: J. Montaner et J. Mellors, Progress in HIV-1 therapy continues on upward track, LANCET, 353(9152), 1999, pp. 565-565
Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy
Authors: Childs, EA Lyles, RH Selnes, OA Chen, B Miller, EN Cohen, BA Becker, JT Mellors, J McArthur, JC
Citation: Ea. Childs et al., Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy, NEUROLOGY, 52(3), 1999, pp. 607-613
A randomized, controlled trial of indinavir, zidovudine, and lamivudine inadults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy
Authors: Hirsch, M Steigbigel, R Staszewski, S Mellors, J Scerpella, E Hirschel, B Lange, J Squires, K Rawlins, S Meibohm, A Leavitt, R
Citation: M. Hirsch et al., A randomized, controlled trial of indinavir, zidovudine, and lamivudine inadults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy, J INFEC DIS, 180(3), 1999, pp. 659-665
Risultati: 1-15 |